This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Medicines Company (MDCO)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 724.41M 687.86M 558.59M 484.73M
Cost of Sales 241.31M 219.18M 163.43M 148.61M
Gross Operating Profit 483.10M 468.68M 395.16M 336.12M
Selling, General, and Administrative Expenses 342.16M 264.96M 171.75M 159.62M
Research & Development 159.18M 146.93M 126.42M 110.18M
Operating Income before D & A (EBITDA) -18.25M 56.80M 96.98M 66.32M
Depreciation & Amortization 46.32M 43.60M 13.91M 8.25M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 42.79M 18.96M 11.14M 19.77M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -23.48M 32.15M 94.21M 77.84M
Interest Expense 15.70M 15.53M 8.00M 0.00
Pre-Tax Income -39.18M 16.62M 86.21M 77.84M
Income Taxes -6.84M 1.36M 35.04M -50.03M
Minority Interest -138.00K -252.00K -84.00K 0.00
Net Income From Continuing Operations -32.35M 15.26M 51.17M 127.88M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -32.35M 15.26M 51.17M 127.88M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -32.21M 15.51M 51.25M 127.88M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-32.35M 15.26M 51.17M 127.88M
Preferred Dividends
Net Income Available To Common -32.35M 15.26M 51.17M 127.88M
Basic EPS from Continuing Ops. -0.50 0.27 0.96 2.39
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.50 0.27 0.96 2.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.50 0.27 0.96 2.39
Basic Normalized Net Income/Share -0.50 0.27 0.96 2.39
EPS fr Continuing Ops. -0.50 0.25 0.93 2.35
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.50 0.25 0.93 2.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.50 0.25 0.93 2.35
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.50 0.25 0.93 2.35
Dividends Paid per Share 0.00 0.00 0.00 0.00
MDCO News

MDCO The Medicines Company

Analysts Ratings for MDCO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MDCO ANALYST REPORT

Brokerage Partners

MDCO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs